HIGHLIGHTS
- who: IDI and collaborators from the Shenyang Pharmaceutical University, China have published the paper: The IDI1/SREBP2 axis drives intrahepatic cholestasis and is a treatment target of San-Huang-Cai-Zhu formula identi ed by sequencing and experiments, in the Journal: (JOURNAL)
- what: The authors propose the following hypothesis based on bioinformatics and literature analysis results.
- how: One-way analysis of variance (ANOVA) was used to The results showed that compared with normal rats Frontiers in Pharmacology frontiersin.org 10.3389/fphar.2023.1093934
SUMMARY
The traditional decoction method . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.